Treatment of acute lung injury by targeting MG53-mediated cell membrane repair. - Wikidata - wikimedia - TriplyDB

Treatment of acute lung injury by targeting MG53-mediated cell membrane repair.

Treatment of acute lung injury by targeting MG53-mediated cell membrane repair.

http://www.wikidata.org/entity/Q33942287

about

Modulation of wound healing and scar formation by MG53 protein-mediated cell membrane repair.An actin-dependent annexin complex mediates plasma membrane repair in muscle.Mitsugumin 53 regulates extracellular Ca(2+) entry and intracellular Ca(2+) release via Orai1 and RyR1 in skeletal muscle.S100 and annexin proteins identify cell membrane damage as the Achilles heel of metastatic cancer cells.Effect of metabolic syndrome on mitsugumin 53 expression and function.Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury.Quantifying Drug-Induced Nanomechanics and Mechanical Effects to Single Cardiomyocytes for Optimal Drug Administration To Minimize Cardiotoxicity.MG53-mediated cell membrane repair protects against acute kidney injury Amelioration of ischemia-reperfusion-induced muscle injury by the recombinant human MG53 protein MG53-IRS-1 (Mitsugumin 53-Insulin Receptor Substrate-1) Interaction Disruptor Sensitizes Insulin Signaling in Skeletal Muscle.Plasma Membrane Repair: A Central Process for Maintaining Cellular Homeostasis.Plasma Membrane Repair in Health and Disease MG53 permeates through blood-brain barrier to protect ischemic brain injury.Dual function of MG53 in membrane repair and insulin signaling.Plasma membrane wounding and repair in pulmonary diseases.A focus on extracellular Ca2+ entry into skeletal muscle.Diabetic cardiomyopathy: catabolism driving metabolism.Non-canonical roles for caveolin in regulation of membrane repair and mitochondria: implications for stress adaptation with age.Zinc in Wound Healing Modulation.Irisin protects mitochondria function during pulmonary ischemia/reperfusion injury.Treatment with Recombinant Human MG53 Protein Increases Membrane Integrity in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.A Bioinspired Alginate-Gum Arabic Hydrogel with Micro-/Nanoscale Structures for Controlled Drug Release in Chronic Wound Healing.Potential mechanism and drug candidates for sepsis-induced acute lung injury.An MG53-IRS1-interaction disruptor ameliorates insulin resistance.

P2860

Q27312202-EA821F5D-EB9E-4E89-B038-3C07AA7758D1 Q30774985-F2749C05-319D-44F7-A9F8-84535FE76824 Q30828501-657BF2E0-A9FD-4043-9B14-465BDA2F9A92 Q35141257-E9D940DC-68D4-4EFA-92D4-C8DFD710DE60 Q35581794-E1A70A1D-0054-4E72-A191-F0AD3F6AD9B7 Q35881667-C365BE80-F7E4-47CF-B895-94BC4DFDA522 Q35887269-29F848FB-FE71-4ADB-AB4D-52E6284F30C5 Q35915152-BA065021-3FD6-4BE9-A520-5C2AA0099047 Q35984468-FC4F860D-DCC0-4CB2-B4F7-FEEE73FF2FA2 Q36181792-7431772A-141E-4235-ABE4-B17B7D517C56 Q36240722-D016ED7B-8E8F-49F7-9BE7-E7AC2815FA60 Q36785977-86DE1491-57B1-4639-849E-02F35A97C864 Q37225580-348CE331-D3A9-4301-9BC6-A40E37EFD0B7 Q38833439-DC5FE576-B732-4504-B562-62FB2655C76E Q39071297-4D58F304-4D67-44EB-BEA8-030DE4C8B5E2 Q42370439-E51AF4E1-F6ED-4EDE-908B-3CEBB2288CE1 Q43178154-FFAA13A5-D27A-4558-97A0-F4AFD34DAB2F Q46747841-AB18C0D0-E6D5-4FEC-ACE0-296DED4FFCA5 Q47237450-55375F19-DC26-4E05-A17F-1D179151F7EB Q47349849-C193146D-7CA4-4A61-8FCD-8F63FACE4C8A Q48020261-B6E1A911-1077-410E-85A9-A214A3E2A775 Q48059170-FC741C27-F2E0-4C6F-9AEE-92B7BA36C9FE Q55258984-C342FB70-668A-47A3-B0B1-9A31F651692D Q55400599-7E509B72-BF36-4F42-8209-5CB9D6049763

P2860

Treatment of acute lung injury by targeting MG53-mediated cell membrane repair.

http://www.wikidata.org/entity/Q33942287

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Treatment of acute lung injury by targeting MG53-mediated cell membrane repair.

@ast

Treatment of acute lung injury by targeting MG53-mediated cell membrane repair.

@en

type

label

Treatment of acute lung injury by targeting MG53-mediated cell membrane repair.

@ast

Treatment of acute lung injury by targeting MG53-mediated cell membrane repair.

@en

prefLabel

Treatment of acute lung injury by targeting MG53-mediated cell membrane repair.

@ast

Treatment of acute lung injury by targeting MG53-mediated cell membrane repair.

@en

P1433

Q33942287-FF51D0EA-92F7-41F5-A6D0-8B453242C6F9

P1476

Q33942287-B52085C9-EEB8-4F68-A416-071F600368C7

P2093

Q33942287-013E1310-5829-4F7B-B785-4ECA2D483C72

Q33942287-096704F8-9204-4F9D-AFAF-BC8C6569D4B2

Q33942287-3EADA628-6066-4F75-BED9-4B0CF467D71A

Q33942287-463667B2-7342-4F36-9B3C-6CDB3A792A1E

Q33942287-4A7D42C6-983C-4D65-A245-349188E2310C

Q33942287-4A9CEB75-82EC-4D3B-8865-8E0E7B8B7191

Q33942287-51619980-E5B2-41FC-A50B-17CCD100ED07

Q33942287-5459E2DF-DE14-4608-ACC1-E6D5EE2014C5

Q33942287-58DFAA86-D7B4-475A-8A79-816D931398B0

Q33942287-5AAB02BD-89D7-4DBA-B84B-CBFF7ADB7484

P2860

Q33942287-028C7479-3613-4E5C-862B-EED0237854E6

Q33942287-0745C74E-78E1-4117-97CA-0D4F00BA8E6C

Q33942287-12A4E949-3EBF-47DD-ABEF-912746999CD6

Q33942287-132E7314-D47D-4DE5-ACAF-4F143A1C3839

Q33942287-152D2D1B-C985-4AE2-B43B-0945513C4616

Q33942287-202A03D8-D344-413C-8AA7-F462299827EB

Q33942287-31F9232F-20BB-408A-8EB0-B376946478E5

Q33942287-327FCA98-11D8-46A1-A3CA-310F19B99D3F

Q33942287-33802E28-2AFE-4182-A41B-A9AF9D1D1015

Q33942287-355DEA64-744A-48BA-930F-5377D7D057B7

P2888

Q33942287-E839C472-51E3-4C37-AF65-37C38D3DBB49

P304

Q33942287-41099244-2A6F-4847-B806-DC37DCC098BE

P31

Q33942287-BD3EA6E3-8777-4E11-92C3-F954EE4C9E49

P356

Q33942287-5030CE7F-DF1E-44F4-89E5-5261949AD983

P407

Q33942287-29503940-C239-4A75-BF39-6FC60A85F380

P478

Q33942287-7A35DB87-3BAC-407E-9C1B-BD91536AB185

P50

Q33942287-86D6C474-C9A0-4B49-892F-9A8C2E4A2EAC

Q33942287-ED410BBC-714F-4F3A-8DA6-6DC7D05BD09D

P577

Q33942287-95F82391-51BD-4573-B35E-DADF46E33CA0

P5875

Q33942287-835B6A8E-0315-4D0E-A296-F1C31F2F16CF

P6179

Q33942287-F165EAE3-2C44-4F7A-B699-C9DA793241E3

P698

Q33942287-654EE2F9-6A0E-4679-B351-3C6C5CA9AC11

P932

Q33942287-104F2C48-F680-467A-BB52-90759249140F

P356

P1433

Nature Communications

P1476

Treatment of acute lung injury by targeting MG53-mediated cell membrane repair.

@en

P2093

Bryan A Whitson

http://www.w3.org/2001/XMLSchema#string

Chunyu Zeng

http://www.w3.org/2001/XMLSchema#string

Gissela Lieber

http://www.w3.org/2001/XMLSchema#string

Haichang Li

http://www.w3.org/2001/XMLSchema#string

Jianjie Ma

http://www.w3.org/2001/XMLSchema#string

John C Hunter

http://www.w3.org/2001/XMLSchema#string

Ken Chen

http://www.w3.org/2001/XMLSchema#string

Miyuki Nishi

http://www.w3.org/2001/XMLSchema#string

Noah Weisleder

http://www.w3.org/2001/XMLSchema#string

Peihui Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Hyperinflation, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease

Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin

Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosis

MG53 regulates membrane budding and exocytosis in muscle cells.

MG53 nucleates assembly of cell membrane repair machinery.

Rat and hamster species differences in susceptibility to elastase-induced pulmonary emphysema relate to differences in elastase inhibitory capacity

MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling

Nonmuscle myosin IIA facilitates vesicle trafficking for MG53-mediated cell membrane repair.

Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy

Immuno-proteomic approach to excitation--contraction coupling in skeletal and cardiac muscle: molecular insights revealed by the mitsugumins.

P2888

P304

4387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS5387

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Hiroshi Takeshima

P577

2014-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264056853

http://www.w3.org/2001/XMLSchema#string

P6179

1029671261

http://www.w3.org/2001/XMLSchema#string

P698

25034454

http://www.w3.org/2001/XMLSchema#string

P932

4109002

http://www.w3.org/2001/XMLSchema#string